NCT00425178View on ClinicalTrials.gov

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 2, 2005

Primary Completion Date

September 2, 2006

Study Completion Date

December 1, 2006

Conditions
Chronic WoundsDiabetesVenous Stasis Ulcers
Interventions
DRUG

FGF-1

Trial Locations (1)

16365

Warren General Hospital, Warren

Sponsors
All Listed Sponsors
collaborator

Warren General Hospital

UNKNOWN

lead

CardioVascular BioTherapeutics, Inc.

INDUSTRY